ChatbotLarge Language ModelAdolescent and Young Adult Cancer SurvivorsReproductive Health
Investigational drug(s) / intervention(s)
ChatbotElectronic brochure
Chatbot: A large language model-driven chatbot that incorporates acceptance and commitment therapy, a verified onco-fertility knowledge base, and relevant policy information.
Electronic brochure: An electronic brochure that contains psychoeducational materials, verified onco-fertility knowledge, and relevant policy information.
Study summary
Reproductive health has emerged as a critical yet overlooked concern among Adolescent and Young Adult (AYA) cancer survivors, given their compromised potential for biological parenthood in prime childbearing years. Large language models (LLMs) offer a promising solution to bridge onco-fertility service gaps by integrating evidence-based knowledge and therapeutic frameworks. This pilot randomized controlled trial aims to assess the feasibility and preliminary effectiveness of an LLM-driven chatbot versus electronic brochure in addressing reproductive concerns among AYA cancer survivors.
Eligibility
Sex
FEMALE
Min age
15 Years
Max age
39 Years
Healthy volunteers
No
Inclusion Criteria:
(1) 15-39-year-old females; (2) cancer diagnosis between ages 15-39; (3) current or prior concerns regarding fertility; (4) proficiency in Mandarin Chinese; and (5) access to a mobile device for intervention delivery.
Exclusion Criteria:
(1) Involvement in the chatbot co-design phases; (2) inability to provide informed consent; (3) significant sensory, cognitive, or psychological impairments precluding meaningful participation; and (4) acute illness at the time of recruitment.
Primary outcome measure(s)
Total interaction time — At 4 weeks, 8 weeks The cumulative time spent interacting with the chatbot or reading the electronic brochure during the study period.
Number of active days — At 4 weeks, 8 weeks The total number of distinct days on which a participant actively engaged with the chatbot or accessed the electronic brochure.
Dropout rate — At 4 weeks, 8 weeks The proportion of randomized participants who do not complete the intervention or outcome measures.
Trial sites (2)
Facility
City
Region
Status
The University of Science and Technology of China
Hefei
Anhui
The Hong Kong Polytechnic University
Kowloon
Hong Kong
More The Hong Kong Polytechnic University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.